Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02279433 |
| Title | A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | AnHeart Therapeutics Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| HonorHealth Research Institute | Scottsdale | Arizona | 85258 | United States | Details | |
| Chao Family Comprehensive Cancer Center of | Orange | California | 92868 | United States | Details | |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
| Dana Farber Cancer Inst. | Boston | Massachusetts | 02215 | United States | Details | |
| New York University | New York | New York | 10016 | United States | Details | |
| South Texas Accelerated Research Therapeutics | San Antonio | Texas | 78229 | United States | Details |